Both Microsoft and Amgen are major dividend payers currently under market scrutiny.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both Microsoft and Amgen are major dividend payers currently under market scrutiny.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Amgen and Microsoft are top holdings in an ETF.Sub-event
Dividend payers Microsoft and Amgen are facing market scrutiny.1 source
Keep exploring
The entities involved
-
Microsoft
American multinational technology corporation
- Nvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.
- Cloud giants, including Microsoft, Amazon, Anthropic, OpenAI, and Google, are benefiting from overall AI market growth while navigating corporate cost containment and future market competition.
-
Amgen
American multinational biopharmaceutical company
Related events
- Investors compare dividend growth strategies of Microsoft and IBM.
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Microsoft and Apple Inc. are both major tech companies seeking investor capital.
- Both Amdocs and Amgen are currently subject to analyst reviews.
- Amgen Inc. trades on the NASDAQ stock exchange.